CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Abcam Plc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Abcam Plc
Clifford Allbutt Building
Cambridge Biomedical Campus, Hills Road
Phone: +44 1223696000p:+44 1223696000 CAMBRIDGE, CB2 0AH  United Kingdom Ticker: ABCABC

Business Summary
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company's purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways. The Company is engaged in data sharing and ecommerce in the life sciences. The Company focuses on helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use its affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences. It has approximately 10 locations located in the world, through life science research hubs, enabling local services and multi-language support.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20196/30/2019Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board Peter V.Allen 6/18/2018 6/18/2018
Chief Executive Officer, Executive Director Alan T.Hirzel 9/8/2014 1/1/2013
Non-Executive Deputy Chairman of the Board Jonathan S.Milner 1/1/2018 4/1/1998
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Epitomics International Inc 863 Mitten Rd Ste 103 BURLINGAME CA United States
MitoSciences, Inc. 1850 Millrace Drive Eugene OR United States

Business Names
Business Name
ABC
Abcam Australia Pty Limited
Abcam Epitomics Holdings, Inc.
17 additional Business Names available in full report.

General Information
Number of Employees: 1,155 (As of 6/30/2019)
Outstanding Shares: 206,015,013 (As of 12/2/2019)
Stock Exchange: LON
Fax Number: +44 1223215215


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, December 06, 2019